full disclosure, I am long ACAD.. have been for 2 yrs or more. Recently sat next to the head of neuroscience research for Pfizer at a dinner (I work at his daughters' school). Brought up ACAD and pimavanserin. He knew it immediately - according to him, the LOOKED at it some time ago.. but it was already too big for them to consider an acquisition. Pfizer, at least, is NOT going to be acquiring ACAD any time soon based on what I was told. I am not trading on this information - I am still long ACAD but I thought I would share this information.
down 67% on this POS. It certainly seems as if we've all been swindled here. what are the opinions out there regarding whether or not it's worth holding on to IDRA, or just selling and taking a big loss?